Kessler, R C
van Loo, H M
Wardenaar, K J
Bossarte, R M
Brenner, L A
Cai, T
Ebert, D D
Hwang, I
Li, J
de Jonge, P
Nierenberg, A A
Petukhova, M V
Rosellini, A J
Sampson, N A
Schoevers, R A
Wilcox, M A
Zaslavsky, A M
Article History
Received: 22 May 2015
Revised: 30 September 2015
Accepted: 26 October 2015
First Online: 5 January 2016
Competing interests
: RCK has been a consultant for Hoffman La Roche, Johnson & Johnson Wellness and Prevention and Sonofi-Aventis Groupe; has served on an advisory board for Lake Nona Institute; and owns stock in DataStat. AAN has been a consultant for Abbott Laboratories, American Psychiatric Association, Appliance Computing (Mindsite), Basliea, Brain Cells, Brandeis University, Bristol-Myers Squibb, Clintara, Corcept, Dey Pharmaceuticals, Dainippon Sumitomo (now Sunovion), Eli Lilly and Company, EpiQ, L.P./Mylan, Forest, Genaissance, Genentech, GlaxoSmithKline, Hoffman La Roche, Infomedic, Lundbeck, Janssen Pharmaceutica, Jazz Pharmaceuticals, Medavante, Merck, Methylation Sciences, Naurex, Novartis, PamLabs, Pfizer, PGx Health, Ridge Diagnostics Shire, Schering-Plough, Somerset, Sunovion, Takeda Pharmaceuticals, Targacept and Teva; consulted through the MGH Clinical Trials Network and Institute (CTNI) for Astra Zeneca, Brain Cells, Dianippon Sumitomo/Sepracor, Johnson and Johnson, Labopharm, Merck, Methylation Science, Novartis, PGx Health, Shire, Schering-Plough, Targacept and Takeda/Lundbeck Pharmaceuticals; had grant/research support from the American Foundation for Suicide Prevention, AHRQ, Brain and Behavior Research Foundation, Bristol-Myers Squibb, Cederroth, Cephalon, Cyberonics, Elan, Eli Lilly, Forest, GlaxoSmithKline, Janssen Pharmaceutica, Lichtwer Pharma, Marriott Foundation, Mylan, NIMH, PamLabs, PCORI, Pfizer Pharmaceuticals, Shire, Stanley Foundation, Takeda and Wyeth-Ayerst; received honoraria from Belvoir Publishing, University of Texas Southwestern Dallas, Brandeis University, Bristol-Myers Squibb, Hillside Hospital, American Drug Utilization Review, American Society for Clinical Psychopharmacology, Baystate Medical Center, Columbia University, CRICO, Dartmouth Medical School, Health New England, Harold Grinspoon Charitable Foundation, IMEDEX, International Society for Bipolar Disorder, Israel Society for Biological Psychiatry, Johns Hopkins University, MJ Consulting, New York State, Medscape, MBL Publishing, MGH Psychiatry Academy, National Association of Continuing Education, Physicians Postgraduate Press, SUNY Buffalo, University of Wisconsin, University of Pisa, University of Michigan, University of Miami, University of Wisconsin at Madison, APSARD, ISBD, SciMed, Slack Publishing and Wolters Klower Publishing; owns stock in Appliance Computing (MindSite), Brain Cells, Medavante; and owns the following copyrights: Clinical Positive Affect Scale and the MGH Structured Clinical Interview for the Montgomery Asberg Depression Scale exclusively licensed to the MGH Clinical Trials Network and Institute (CTNI). MAW is an employee of Janssen Pharmaceuticals. HMvL, KJW, RMB, LAB, TC, DDE, IH, JL, PdJ, MVP, AJR, NAS, RAS and AMZ declare no conflict of interest.